Baillie Gifford Health Innovation Equities Fund ALNY Holdings History
Baillie Gifford Health Innovation Equities Fund's Alnylam Pharmaceuticals Inc Holding Summary
As of 2024-09-30, Baillie Gifford Health Innovation Equities Fund held 1,781.00 shares of Alnylam Pharmaceuticals Inc(ALNY), totaling $489,830.00. This investment constitutes 7.18% of their stock portfolio, and Baillie Gifford Health Innovation Equities Fund now holds 0% of the outstanding Alnylam Pharmaceuticals Inc(ALNY) stock.
The initial trade took place in 2022Q1. And since then Baillie Gifford Health Innovation Equities Fund has made 5 purchases of ALNY, at an average price of $193.45, for a total of 7,572.00 shares. In addition, there have been 5 sales at an average price of $213.94 for 5,791.00 shares. Based on historical transaction data and ALNY's current price of $325.64, Baillie Gifford Health Innovation Equities Fund's estimated gain on his ALNY holdings is $354,061.45, reflecting a 24.17% gain to date.
Baillie Gifford Health Innovation Equities Fund ALNY ($325.64) Holding Chart
Baillie Gifford Health Innovation Equities Fund ALNY ($325.64) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
